Internal Medicine, Hematology & Oncology · Spartanburg, SC
NPI
1619364668
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
101 E Wood St
Spartanburg, SC, 29303
Phone (864) 560-7050
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
1,620 services
Medicare patients, 2024
566
Average age 73
Drug cost, 2024
$2.2M
2,757 prescriptions
Company payments, 2025
$872
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Isaac E Alwine was code 99214 (office e&m - established), 441 times for 237 patients. In total Isaac E Alwine billed 1,620 services in 12 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 441 | 237 | $63.24 | $28K |
| 99215 Office E&M - Established | Office | 371 | 190 | $107.36 | $40K |
| 99214 Office E&M - Established | Facility | 220 | 120 | $63.22 | $14K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 213 | 107 | $23.35 | $4,973 |
| 99215 Office E&M - Established | Facility | 140 | 58 | $107.19 | $15K |
| 99213 Office E&M - Established | Office | 66 | 57 | $39.83 | $2,629 |
| 99233 Hospital E&M - Subsequent | Facility | 47 | 22 | $92.82 | $4,363 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 38 | 19 | $24.41 | $928 |
| 99213 Office E&M - Established | Facility | 31 | 26 | $49.53 | $1,536 |
| 99223 Hospital E&M - Initial | Facility | 28 | 21 | $135.26 | $3,787 |
By year: 2022 $88K for 1,157 services; 2023 $86K for 1,230 services; 2024 $117K for 1,620 services.
Medicare prescription drug claims, 2024
In 2024, the drug Isaac E Alwine prescribed most often to Medicare patients was Letrozole, with 977 prescriptions and refills. In total Isaac E Alwine wrote 2,757 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 977 | 1,809 | 242 | $16K |
| Ibandronate Sodium Generic | 355 | 648 | 97 | $7,910 |
| Anastrozole Generic | 122 | 225 | 42 | $1,318 |
| Ondansetron Odt Ondansetron | 74 | 74 | 36 | $742 |
| Ondansetron Hcl Generic | 60 | 60 | 27 | $521 |
| Prochlorperazine Maleate Generic | 60 | 60 | 33 | $538 |
| Loperamide Loperamide Hcl | 59 | 61 | 35 | $421 |
| Hydroxyurea Generic | 48 | 62 | Under 11 | $694 |
| Exemestane Generic | 46 | 102 | 14 | $10K |
| Tamoxifen Citrate Generic | 44 | 74 | 13 | $693 |
| Gabapentin Generic | 40 | 42 | 11 | $296 |
| Verzenio Abemaciclib | 40 | 40 | Under 11 | $601K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 37 | 37 | 13 | $796 |
| Prednisone Generic | 35 | 36 | 13 | $152 |
| Pantoprazole Sodium Generic | 34 | 58 | Under 11 | $232 |
Brand drugs: 226 claims; generic drugs: 2,531 claims; opioid claims: 134.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Isaac E Alwine $872 ($872 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $203.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 9 | $203 |
| Abbvie Inc. ABBV | 7 | $114 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $97.92 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $79.15 |
| Daiichi Sankyo Inc. 4568.T | 3 | $71.19 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.97 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $47.78 |
| Gilead Sciences, Inc. GILD | 2 | $44.5 |
| GlaxoSmithKline, LLC. GSK | 2 | $42.45 |
| Iovance Biotherapeutics, Inc. IOVA | 1 | $25.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.